Shares of Spectral Medical Inc. (TSE:EDT – Get Free Report) rose 10.8% on Monday . The company traded as high as C$0.72 and last traded at C$0.72. Approximately 337,885 shares changed hands during mid-day trading, an increase of 574% from the average daily volume of 50,144 shares. The stock had previously closed at C$0.65.
Spectral Medical Price Performance
The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61. The company has a 50-day moving average price of C$0.54 and a 200-day moving average price of C$0.58. The firm has a market capitalization of C$210.94 million, a P/E ratio of -10.71 and a beta of 0.96.
About Spectral Medical
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Featured Stories
- Five stocks we like better than Spectral Medical
- What Are Dividend Contenders? Investing in Dividend Contenders
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Price Targets on NVIDIA Rise in Front of Earnings
- What Are Some of the Best Large-Cap Stocks to Buy?
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
